TY - JOUR
T1 - Abnormally high failure rate for femoral angioplasty in patients with pseudoxanthoma elasticum
AU - Ammi, Myriam
AU - Kranenburg, Guido
AU - Omarjee, Loukman
AU - Martin, Ludovic
AU - Spiering, Wilko
AU - Lefthériotis, Georges
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Pseudoxanthoma elasticum (PXE) is an inherited disease characterized by skin lesions, central blindness, and progressive peripheral occlusive disease. Severe claudication is a frequent symptom for which angioplasty represents a possible therapeutic avenue. We report the outcomes of four patients with PXE treated by angioplasty and stenting of the superficial femoral artery in two centers. These patients exhibited an abnormal failure rate for angioplasty and stenting of the superficial femoral artery, suggesting an as yet unknown susceptibility in such patients. In the absence of further evidence, we do not recommend arterial angioplasty with stenting as a primary surgical approach in PXE patients with femoral artery lesions.
AB - Pseudoxanthoma elasticum (PXE) is an inherited disease characterized by skin lesions, central blindness, and progressive peripheral occlusive disease. Severe claudication is a frequent symptom for which angioplasty represents a possible therapeutic avenue. We report the outcomes of four patients with PXE treated by angioplasty and stenting of the superficial femoral artery in two centers. These patients exhibited an abnormal failure rate for angioplasty and stenting of the superficial femoral artery, suggesting an as yet unknown susceptibility in such patients. In the absence of further evidence, we do not recommend arterial angioplasty with stenting as a primary surgical approach in PXE patients with femoral artery lesions.
UR - http://www.scopus.com/inward/record.url?scp=84951266359&partnerID=8YFLogxK
U2 - 10.1016/j.jvsc.2015.10.001
DO - 10.1016/j.jvsc.2015.10.001
M3 - Article
AN - SCOPUS:84951266359
SN - 2352-667X
VL - 1
SP - 276
EP - 278
JO - Journal of Vascular Surgery Cases
JF - Journal of Vascular Surgery Cases
IS - 4
ER -